ALACT — Acticor Biotech SA Balance Sheet
0.000.00%
Last trade - 00:00
- €51.45m
- €50.55m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 12.9 | 7.59 | 11.3 | 6.6 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 1.38 | 1.93 | 4.28 | 4.84 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 14.5 | 10.1 | 16.9 | 11.7 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.228 | 0.181 | 0.098 | 0.014 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Total Assets | 15.4 | 11 | 17.9 | 12.9 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 5.16 | 6.38 | 4.06 | 6.7 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 6.37 | 9.3 | 6.86 | 15.2 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 9.03 | 1.72 | 11 | -2.24 |
Total Liabilities & Shareholders' Equity | 15.4 | 11 | 17.9 | 12.9 |
Total Common Shares Outstanding |